Synopsis of Social media discussions
The group's overall tone underscores strong interest in the study's clinical implications, with phrases such as 'key data' and 'editor's choice' demonstrating engagement. Posts reference specific surveillance methods like scheduled ERCP and annual MRI, highlighting the potential shift in practice, though they acknowledge limitations like the lack of significant difference in some outcomes, which tempers the perceived impact.
Agreement
Moderate agreementMany discussions reflect support for the findings, emphasizing the potential benefits of scheduled ERCP for reducing serious liver-related events.
Interest
High level of interestParticipants show high interest with phrases like 'key data' and 'editor's choice,' indicating they value the research’s implications.
Engagement
Moderate level of engagementPosts reference specific modalities like ERCP and MRI, and include expert commentary, suggesting moderate engagement with the study details.
Impact
Moderate level of impactThe discussions suggest the study could influence clinical decisions, especially regarding monitoring strategies, though some nuance about statistical significance moderates the perceived impact.
Social Mentions
YouTube
1 Videos
2 Posts
8 Posts
Metrics
Video Views
77
Total Likes
21
Extended Reach
26,667
Social Features
11
Timeline: Posts about article
Top Social Media Posts
Posts referencing the article
Comparison of Surveillance Strategies in Primary Sclerosing Cholangitis Management
This study compares three surveillance strategies for primary sclerosing cholangitis: scheduled ERCP, annual MRI, and ondemand ERCP, highlighting that scheduled ERCP is associated with the lowest incidence of serious liver-related events.
-
RT @IUGastro:
view full postJuly 29, 2025
1
-
Indiana University Gastroenterology and Hepatology
@IUGastro (Twitter)July 29, 2025
6
1
-
Daniel Luna
@DaniLuna7 (Twitter)What’s the best way to monitor primary sclerosing cholangitis (PSC) patients? New #VisualAbstract ⚡ Surveillance strategies in PSC — ERCP vs MRI. Key data in the slide
view full postJune 11, 2025
-
Aparato Digestivo
@DigesGomezUlla (Twitter)RT @endoscopyjrnl: #AuthorCommentary: Martti Färkkilä on "Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-…
view full postApril 26, 2025
1
-
Endoscopy Journal
@endoscopyjrnl (Twitter)#AuthorCommentary: Martti Färkkilä on "Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study" Watch: https://t.co/FEdMP2uCXk Read: https://t.co/cCVsmgWsbW Nina Barner-Rasmussen et al.
view full postApril 26, 2025
3
1
-
Mauro
@Mauritobarce (Twitter)RT @endoscopyjrnl: Editor's Choice: Surveillance of primary sclerosing cholangitis – scheduled or on-demand ERCP with annual MRI? Find the…
view full postApril 25, 2025
3
-
Matheus Souza
@mhenrique028 (Twitter)RT @endoscopyjrnl: Editor's Choice: Surveillance of primary sclerosing cholangitis – scheduled or on-demand ERCP with annual MRI? Find the…
view full postApril 25, 2025
3
-
Endoscopy Journal
@endoscopyjrnl (Twitter)Editor's Choice: Surveillance of primary sclerosing cholangitis – scheduled or on-demand ERCP with annual MRI? Find the article at: https://t.co/cCVsmgWsbW Nina Barner-Rasmussen et al. https://t.co/oM4fgoROdh
view full postApril 25, 2025
12
3
Abstract Synopsis
- This study compares three surveillance strategies for primary sclerosing cholangitis (PSC): scheduled ERCP, annual MRI, and ondemand ERCP, to determine their impact on patient outcomes and the risk of hepatobiliary cancers.
- Results showed that patients undergoing scheduled ERCP had the lowest incidence of serious liver-related events like malignancy, liver transplant, or death, suggesting it may be more effective than the other strategies.
- Although scheduled ERCP reduced the incidence of cholangiocarcinoma compared to other methods, the differences were not statistically significant, and no differences in liver-related death rates were observed across strategies.
richar hipolito
@richar_andres (Twitter)